最後更新 2024-05-16 07:32:41 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

4.3%


截至2024-03-30

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

Haemonetics Corporation是一家醫療保健公司,提供醫療產品和解決方案。它通過三個部門運營:血漿、血液中心和醫院。該公司提供自動化血漿收集設備、相關一次性用品和軟件,包括NexSys PCS和PCS2血漿置換設備及相關一次性用品和靜脈注射溶液,以及整合信息技術平台,供血漿客戶管理捐血者、運營和供應鏈;以及NexLynk DMS捐血者管理系統。它還提供自動化血液成分和手動全血收集系統,例如MCS品牌的分離設備,用於從捐血者收集特定的血液成分;一次性全血收集和成分存儲套裝;SafeTrace Tx血庫信息系統;以及BloodTrack血液管理軟件,一套結合軟件和硬件組件的血液管理和床邊輸血解決方案,同時也是醫院血庫信息系統的延伸。此外,該公司還提供醫院產品,包括提供患者整體止血狀況全面評估的TEG、ClotPro和HAS止血分析儀系統;TEG Manager軟件,可連接醫院各處的各種TEG分析儀,讓臨床醫生遠程訪問活動和歷史測試結果,以指導治療決策;以及Cell Saver Elite +,一種自體血液恢復系統,用於心血管、骨科、創傷、移植、血管、產科和婦科手術。它通過直接銷售團隊、獨立經銷商和銷售代表銷售其產品。Haemonetics Corporation成立於1971年,總部位於馬薩諸塞州波士頓。

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Instruments & Supplies

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning